1. Home
  2. BRSP vs IRWD Comparison

BRSP vs IRWD Comparison

Compare BRSP & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BrightSpire Capital Inc.

BRSP

BrightSpire Capital Inc.

HOLD

Current Price

$5.94

Market Cap

773.2M

Sector

Real Estate

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$4.61

Market Cap

850.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRSP
IRWD
Founded
2017
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
773.2M
850.8M
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
BRSP
IRWD
Price
$5.94
$4.61
Analyst Decision
Buy
Hold
Analyst Count
3
4
Target Price
$6.00
$3.68
AVG Volume (30 Days)
618.2K
2.8M
Earning Date
02-17-2026
02-26-2026
Dividend Yield
10.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.18
Revenue
$330,894,000.00
$338,987,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$10.02
$37.22
P/E Ratio
N/A
$25.75
Revenue Growth
N/A
N/A
52 Week Low
$4.16
$0.53
52 Week High
$6.32
$5.78

Technical Indicators

Market Signals
Indicator
BRSP
IRWD
Relative Strength Index (RSI) 48.74 51.59
Support Level $5.88 $4.42
Resistance Level $6.07 $5.13
Average True Range (ATR) 0.14 0.35
MACD -0.01 -0.11
Stochastic Oscillator 21.74 27.91

Price Performance

Historical Comparison
BRSP
IRWD

About BRSP BrightSpire Capital Inc.

BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Share on Social Networks: